targeted anti-angiogenesis therapy (Targesome)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug Nametargeted anti-angiogenesis therapy (Targesome)
Drug Alias Namecancer therapy (Targesome)IA-NP-Y90 (Targesome)nanoparticles (Targesome)anti-Flk-1-NP-Y90 (Targesome)IA-NP-Y90
ClassificationRadiation-emitting products > Radioactive therapeutic agentSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin antagonists
TargetsIntegrin
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTargesome Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTargesome Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A